Showing results (1141-1150 of 1,403) with videos related to
Sort By:
Pageof 141
Transfusion|April 12, 2014
Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donorsTarana T A Lucky, Clive R Seed, Daniel Waller, et al.Scientific Reports|October 30, 2015
High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane modelDesmond Pink, Keith A Luhrs, Longen Zhou, et al.Journal of the American Chemical Society|August 17, 2017
Room-Temperature Ring-Opening of Quinoline, Isoquinoline, and Pyridine with Low-Valent TitaniumSeung-Yeol Baek, Takashi Kurogi, Dahye Kang, et al.The Journal of Small Animal Practice|December 16, 2021
Surgical management of superficial digital flexor tendon luxation in dogs: 48 cases (2005-2020)D Goh, A House, A P Moores, et al.Journal of the American Chemical Society|July 10, 2026
Large Magnetoresistance in Tetracyanoquinodimethane (TCNQ) Charge-Transfer Complex of a Stable <i>S</i> = 1/2 Tetrazolinyl RadicalHaoxin Guo, Hyunki Yeo, Zhimin Yang, et al.Carbohydrate Polymers|July 23, 2021
Chitosan as capping agent in a robust one-pot procedure for a magnetic catalyst synthesisTomer A Dickstein, Ergang Zhou, Kian K Hershberger, et al.Nanoimpact|May 13, 2022
How can we justify grouping of nanoforms for hazard assessment? Concepts and tools to quantify similarityNina Jeliazkova, Eric Bleeker, Richard Cross, et al.Journal of the American Chemical Society|November 28, 2008
Understanding and predicting distorted T- versus Y-geometries for neutral chromous complexes supported by a sterically encumbering beta-diketiminate ligandHongjun Fan, Debashis Adhikari, Anas A Saleh, et al.Oncotarget|August 29, 2015
A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2Andrew R Lavik, Fei Zhong, Ming-Jin Chang, et al.The Journal of Investigative Dermatology|March 8, 2023
Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Center ExperienceAntony Raharja, Zehra Arkir, Giulia Rinaldi, et al.Pageof 141